Large-Scale Deployment of DeepL Translate and DeepL Write Begins at Daiichi Sankyo
Global pharmaceutical leader adopts DeepL for Enterprise, harnessing cutting-edge Language AI technology to streamline global operations and drive company-wide innovation
Tokyo, JP — Jun 2, 2025 — DeepL, a leading global Language AI company, today announced the large-scale deployment of its AI-powered solutions, DeepL Translate Pro and DeepL Write Pro, across its global operations of pharmaceutical company Daiichi Sankyo Co., Ltd. The implementation leverages DeepL’s specialized enterprise solution, DeepL for Enterprise.
The deployment is part of a broader initiative for company-wide transformation through advanced digital technologies. DeepL’s highly accurate and secure AI-powered translation and language solutions have been identified as a strategic investment, essential for enabling seamless communication with employees, partners and other stakeholders worldwide. The rollout of DeepL for Enterprise began on March 31, 2025, with the goal of enhancing global collaboration and operational efficiency.
Since its inception, DeepL has been at the forefront of AI-based communication technology, becoming the specialized Language AI provider of choice for businesses, governments and other organizations worldwide. Unlike general-purpose AI systems, DeepL's cutting-edge translation and writing solutions rely on specialized AI models specifically tuned for the language, resulting in more precise translations for a variety of use cases and a reduced risk of hallucinations and misinformation. In enterprise translation and writing, accuracy is paramount, making DeepL's specialized Language AI platform one of the most reliable and preferred solutions for businesses.
An extension of DeepL's cutting-edge Language AI platform for businesses, DeepL for Enterprise is specifically designed to address the growing needs of large organizations looking to deploy AI – offering custom pricing and packaging, advanced personalization features, enterprise-grade security features critical for the protection of business-critical content, global deployment and management capabilities, and more. Today, over 200,000 businesses worldwide leverage DeepL's cutting-edge platform, including its enterprise-ready solution, for better translations and writing.
Jaroslaw Kutylowski, founder and CEO of DeepL, added, “DeepL is thrilled to partner with Daiichi Sankyo to bring DeepL’s powerful Language AI solutions to its employees around the world. In an industry that operates at the forefront of scientific innovation, pharma also demands exceptional precision, clarity and contextual nuance in every language interaction – and DeepL is uniquely positioned to meet these needs. Our platform is proven to drive significant ROI, delivering enterprise-grade security, advanced personalization functionality and human-like quality and accuracy. We look forward to supporting Daiichi Sankyo’s ongoing transformation and helping drive innovation, speed and growth across their global operations.”
To learn more about DeepL for Enterprise, visit https://www.deepl.com/enterprise.
About DeepL
DeepL is on a mission to break down language barriers for businesses everywhere. Over 200,000 businesses and governments and millions of individuals across 228 global markets trust DeepL's Language AI platform for human-like translation in both written and spoken formats, as well as natural, improved writing. Designed with enterprise security in mind, companies around the world leverage DeepL's AI solutions that are specifically tuned for language to transform business communications, expand markets and improve productivity. Founded in 2017 by CEO Jaroslaw (Jarek) Kutylowski, DeepL today has over 1,000 passionate employees and is supported by world-renowned investors including Benchmark, IVP and Index Ventures. For more information, visit deepl.com.